AnaptysBio, Inc.
corporate_fare Company Profile
AnaptysBio, Inc. (NASDAQ:ANAB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 46 items for ANAB at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- AnaptysBio Soars to 52-Week High Post-Spinoff; First Tracks Biotherapeutics Shares Decline
- AnaptysBio Approves Spin-Off of First Tracks Biotherapeutics, Authorizes $100M Buyback, and Appoints Key Director
- $145M Private Placement Secured for AnaptysBio's Spin-Off, First Tracks Biotherapeutics
- AnaptysBio Posts $49.6 Million Net Income in Q4
- AnaptysBio to Spin Off Biopharma Unit as First Tracks Biotherapeutics in Q2 2026 to Unlock Value
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$234.6M
Net Income
-$13.23M
Diluted EPS
-$0.46
Op. Cash Flow
$19.7M
Free Cash Flow
$19.61M
Operating Income
$47.9M
Cash & Equivalents
$238.2M
Debt / Equity
0.00×
Net Margin
-5.6%
Shares Outstanding
28.02M sh
Source: 10-K · filed 2026-04-28 · accession 0001193125-26-187044
show_chartPrice Chart
Loading chart...
feed ANAB - Filings & News (Page 3)
ANAB
Apr 20, 2026, 1:15 PM EDT
Price at Filing:
$50.42
Real-time Price:
$46.63
Change:
-$3.78 (-8%)
Market Cap:
$1.386B
ANAB
Mar 27, 2026, 9:19 AM EDT
Price at Filing:
$64.02
Real-time Price:
$46.63
Change:
-$17.39 (-27%)
Market Cap:
$1.386B
ANAB
Mar 27, 2026, 9:02 AM EDT
Price at Filing:
$64.20
Real-time Price:
$46.63
Change:
-$17.57 (-27%)
Market Cap:
$1.386B
ANAB
Mar 03, 2026, 4:15 PM EST
Price at Filing:
$52.83
Real-time Price:
$46.63
Change:
-$6.20 (-12%)
Market Cap:
$1.386B
ANAB
Mar 03, 2026, 4:15 PM EST
Price at Filing:
$52.83
Real-time Price:
$46.63
Change:
-$6.20 (-12%)
Market Cap:
$1.386B
ANAB
Jan 09, 2026, 5:17 PM EST
Price at Filing:
$44.67
Real-time Price:
$46.63
Change:
+$1.96 (+4%)
Market Cap:
$1.386B